Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-Up in Decentralized Settings (The ACCELL Interventional Trial)

NCT06324110 is registered in ClinicalTrials.gov with Fred Hutchinson Cancer Center as lead sponsor.

NCT NCT06324110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06324110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-Up in Decentralized Settings (The ACCELL Interventional Trial)
Lead sponsor
Fred Hutchinson Cancer Center
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
March 1, 2025
Completion date
October 31, 2027
Enrollment
6,772 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung carcinoma